Severe asthma paediatric - change or continuing authority application form (PB385)

Use this form to apply to change PBS-subsidised treatment with dupilumab or omalizumab, or to continue PBS-subsidised treatment with dupilumab for patients 6 to under 12 years with uncontrolled severe asthma or uncontrolled severe allergic asthma.

Page last updated: 1 September 2025.
QC 83102